Recent News

• 09.09.2025 - Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
• 09.09.2025 - Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
• 09.09.2025 - Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
• 09.09.2025 - Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
• 08.14.2025 - Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split
• 08.14.2025 - Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split
• 08.14.2025 - Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split
• 08.14.2025 - Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split

Recent Filings

• 09.09.2025 - 8-K Current report
• 09.09.2025 - EX-99.1 EX-99.1
• 08.27.2025 - 8-K Current report
• 08.26.2025 - 8-K Current report
• 08.26.2025 - 8-K/A Current report
• 08.22.2025 - 8-K Current report
• 08.22.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 08.22.2025 - EX-99.1 EX-99.1
• 08.18.2025 - 8-K Current report
• 08.15.2025 - S-3 Registration statement under Securities Act of 1933